Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The metastatic melanoma study record is now displayed, including its completed status, enrollment, eligibility criteria, treatment arms, outcomes, and Norwegian study locations, instead of an error page.
    Difference
    53%
    Check dated 2026-11-08T14:24:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:46:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice announces that NIH is transitioning from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:37:25.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision updates from v3.7.1 to v3.7.2 while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:41:15.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T20:40:52.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The NCT02872259 study page now displays a 403 Forbidden error instead of the study record content, with the standard header/footer shown; the content previously containing the trial details has been removed.
    Difference
    19%
    Check dated 2026-09-20T22:23:16.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.